{
    "type": "ETP",
    "ucits": true,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": true,
    "complex_factors": [
        "Synthetic replication via FX forward contracts",
        "Use of collateralised debt security structure",
        "Inverse exposure to CHF vs EUR",
        "Counterparty risk from issuer and derivative counterparties",
        "Rolling of forward contracts with potential roll costs and tracking error"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Short CHF Long EUR product is a UCITS-eligible Exchange Traded Product (ETP) that provides inverse exposure to the CHF relative to EUR by tracking the MSFXSM Short Swiss Franc/Euro Total Return Index. The product achieves its investment objective through daily performance of FX forward contracts, which are derivative instruments, indicating synthetic replication. The product is described as a collateralised debt security governed by Jersey law, exposing investors to counterparty risk from the issuer and derivative counterparties. The KIID explicitly states the product is 'not simple and may be difficult to understand' and requires specific knowledge or experience of similar products. The risk indicator is medium-low (3/7), but the product carries risks related to currency fluctuations, counterparty default, and the effects of rolling forward contracts, which can cause tracking error and complexity. There is no leverage ratio above 1:1, but the product provides inverse exposure, which is a complexity trigger. Costs include management fees and transaction costs related to buying and selling underlying derivatives. The product does not have capital protection or structured contingent features but the synthetic nature, inverse exposure, and derivative usage classify it as complex under MiFID II. The PRIIPs KID and factsheet confirm the use of FX forwards and collateralised debt security structure, reinforcing the synthetic and derivative-based nature of the product. Therefore, despite a moderate risk rating, the product\u2019s synthetic replication, use of swaps/forwards, inverse exposure, and counterparty risk lead to a classification of complex."
}